A Clinical Trial to Evaluate the Safety and Efficacy of Enjuvia 0.3 mg for the Treatment of Vulvovaginal Atrophy
Status:
Completed
Trial end date:
2006-02-01
Target enrollment:
Participant gender:
Summary
This is a two-arm, randomized, double-blind, parallel-group, placebo-controlled study to
evaluate the efficacy of Enjuvia 0.3 mg tablets for the treatment of moderate to severe
symptoms of vulvovaginal atrophy in postmenopausal women with or without a hysterectomy
and/or oophorectomy.
Phase:
Phase 3
Details
Lead Sponsor:
Duramed Research
Treatments:
Estrogens Estrogens, Conjugated (USP) Estrogens, conjugated synthetic A Estrogens, conjugated synthetic B